Histone deacetylase (HDAC) inhibitors play crucial roles in restoring the balance of acetylation and deacetylation of lysine residues of histones and nonhistone proteins and are used to treat several diseases, including cancer (Table 3). Here, HDAC9 is linked to cancer.